Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Carasent AB (publ)'s Enterprise Value is kr1,622.4 Mil.
Carasent AB (publ)'s Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was kr52.3 Mil. Therefore, Carasent AB (publ)'s EV-to-FCF for today is 31.02.
The historical rank and industry rank for Carasent AB (publ)'s EV-to-FCF or its related term are showing as below:
LTS:0H9M'
s EV-to-FCF Range Over the Past 10 Years
Min: -11466.07 Med: -6.85 Max: 1181.56
Current: 31.53
During the past 13 years, the highest EV-to-FCF of Carasent AB (publ) was 1181.56. The lowest was -11466.07. And the median was -6.85.
LTS:0H9M's EV-to-FCF is ranked worse than 71.36% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.06
vs LTS:0H9M: 31.53
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Carasent AB (publ) (LTS:0H9M) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Carasent AB (publ)'s PE Ratio (TTM) for today is calculated as:
Carasent AB (publ)'s share price for today is kr20.60.
Carasent AB (publ)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.670.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Carasent AB (publ) EV-to-FCF Related Terms
Carasent AB (publ) EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Carasent AB (publ)'s EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Carasent AB (publ)'s EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carasent AB (publ) EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Carasent AB (publ)'s EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Carasent AB (publ)'s EV-to-FCF falls into.
Carasent AB (publ)'s current Enterprise Value is kr1,622.4 Mil.
Carasent AB (publ)'s Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr52.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carasent AB (publ) (LTS:0H9M) has a EV-to-FCF of 31.02 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Carasent AB (publ) and its competitors. According to the industry distribution chart, Carasent AB (publ) ranks #289 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 71.4%.
Is Carasent AB (publ)'s EV-to-FCF too high?
Carasent AB (publ)'s current EV-to-FCF is 31.02. The Healthcare Providers & Services industry median EV-to-FCF is 18.06. Carasent AB (publ)'s value of 31.02 is 71.8% above this industry median. Based on the distribution chart, Carasent AB (publ) ranks #289 out of 405 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Carasent AB (publ) has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Carasent AB (publ) ranks #289 out of 405 companies for EV-to-FCF. This places Carasent AB (publ) in the lower half of its industry. The industry median EV-to-FCF is 18.06. Carasent AB (publ)'s value of 31.02 is 71.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.06, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carasent AB (publ)'s current EV-to-FCF of 31.02 is 71.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Carasent AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carasent AB (publ)'s current EV-to-FCF is 31.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Carasent AB (publ) (LTS:0H9M) has a current EV-to-FCF of 31.02. The stock's GF Value™ is kr24.22, compared to a current price of kr20.60 — trading 14.9% below its estimated fair value. The current EV-to-FCF is 31.02 and 71.8% above the Healthcare Providers & Services industry median of 18.06. Carasent AB (publ)'s overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Carasent AB (publ) (LTS:0H9M), the current EV-to-FCF is 31.02 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carasent AB (publ) (LTS:0H9M) Overvalued in 2026?
Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued.
The current stock price of kr20.60 is trading 14.9% below its estimated GF Value™ of kr24.22.
Key valuation signals for LTS:0H9M:
EV-to-FCF: 31.02
GF Value™: kr24.22 vs. price of kr20.60 (14.9% below fair value)
Industry Position: 71.8% above the Healthcare Providers & Services median (#289 of 405)
No single metric tells the full story. See the LTS:0H9M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
80GF Score
Get the complete analysis for LTS:0H9M
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0H9M has been successfully added to your 
